Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

407.83 20.58 +5.31%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 65.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, BeOne Medicines Ltd. - Sponsored ADR (ONC) trades at a P/S ratio of 6.6×. Over the past ten years it has ranged from 4.8× (January 2025) to 717× (September 2017); the current reading is higher than 15% of that period. That is below the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ONC/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="BeOne Medicines Ltd. - Sponsored ADR P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ONC/metrics/ps-ratio">BeOne Medicines Ltd. - Sponsored ADR (ONC) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	6.2×	21.50%
FY2024	5.1×	(32.08%)
FY2023	7.5×	(54.48%)
FY2022	16.5×	(22.76%)
FY2021	21.4×	(69.40%)
FY2020	69.8×	200.38%
FY2019	23.2×	(40.74%)
FY2018	39.2×	122.40%
FY2017	17.6×	(89.48%)
FY2016	168×	484.30%

Period	P/S ratio	Change
Sep 2026	6.2×	19.13%
Jun 2026	5.2×	(9.64%)
Mar 2026	5.7×	(7.42%)
Dec 2025	6.2×	(17.88%)
40 more quarters	Free account

Against its own ten years

Low 4.8× High 717×

Ten-year median 19.8×

Current reading's percentile 15

Company	P/S ratio
INCY Incyte Corporation compare	4.0×
ONC BeOne Medicines Ltd. - Sponsored ADR	6.6×
GMAB Genmab A/S Sponsored ADR compare	7.9×
BNTX BioNTech SE Sponsored ADR compare	7.9×
ARGX argenex SE compare	9.5×
RPRX Royalty Pharma PLC compare	11.5×
INSM Insmed, Inc. compare	15.6×
RVMD Revolution Medicines, Inc. compare	185×
ROIV Roivant Sciences Ltd. compare	3,528×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

BeOne Medicines Ltd. - Sponsored ADR (ONC) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ONC

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ONC

Stockrow Weekly